XM does not provide services to residents of the United States of America.
H
H

HCA

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. Commercial Metals, M&T Bank, Simon Property

U.S. RESEARCH ROUNDUP-Commercial Metals, M&T Bank, Simon Property Sept 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Commercial Metals, M&T Bank Corp and Simon Property Group, on Tuesday. HIGHLIGHTS * Autodesk Inc ADSK.O : Citigroup raises target price to $325 from $316 * Builders Firstsource BLDR.N : Oppenheimer raises target price to $205 from $190 * Commercial Metals Co CMC.N : Jefferies initiates with buy rat
A
B
G
H
S
A
G
I
L
M
U

U.S. Advance Auto Parts, Chewy, Workday

U.S. RESEARCH ROUNDUP-Advance Auto Parts, Chewy, Workday Aug 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Advance Auto Parts, Chewy and Workday, on Friday. HIGHLIGHTS * Advance Auto Parts Inc AAP.N : JP Morgan cuts target price to $43 from $55 * Chewy CHWY.N : Piper Sandler raises to overweight from neutral * Intuit Inc INTU.O : Jefferies raises target price to $790 from $770 * Williams-Sonoma Inc WSM.N : TD Co
A
A
A
B
I
J
N
N
R
R
H
A

US corporate bond issuance jumps after brief pullback

US corporate bond issuance jumps after brief pullback By Matt Tracy Aug 7 (Reuters) - U.S. corporate borrowers flooded the market for new bond sales on Wednesday after sitting on the sidelines earlier in the week due to a spike in borrowing costs. At least 17 corporate issuers tapped the U.S. bond market on Wednesday, including multi-billion dollar deals for tech giant Meta Platforms META.O , automaker BMW BMWGC.UL and for-profit healthcare provider HCA Inc HCA.N .
B
H

U.S. Edwards Lifesciences, National Bank Holdings, Sage Therapeutics

U.S. RESEARCH ROUNDUP-Edwards Lifesciences, National Bank Holdings, Sage Therapeutics July 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Edwards Lifesciences, National Bank Holdings and Sage Therapeutics, on Thursday. HIGHLIGHTS * Edwards Lifesciences Corp EW.N : JP Morgan cuts to neutral from overweight * National Bank Holdings Corp NBHC.N : Piper Sandler cuts to neutral from overweight * Sage Therapeutics Inc S
A
A
C
C
G
S
C
E
H
I
A
A
E
L

Universal Health Services beats second-quarter profit estimates on higher hospital admissions

Universal Health Services beats second-quarter profit estimates on higher hospital admissions July 24 (Reuters) - Hospital operator Universal Health Services UHS.N beat Wall Street estimates for second-quarter profit on Wednesday, helped by higher patient admissions. Shares of the company were up 6.2% at $197.50 after the bell. The hospital operator also raised its annual adjusted profit forecast to $15.40 to $16.20 per share, compared to its previous estimate of $13 to $14 per share.
H
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.